US Patent 7989438 Therapeutic compounds
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+381 characters)
Article
Patent abstract
A class of macrocyclic compounds of formula (I), wherein R7, A, Ar, B, D, F, M, Q1, Q2, W, X, Y and Z are defined herein, that are useful as inhibitors of viral proteases, particularly the hepatitis C virus (HCV) NS3 protease, are provided. Also provided are processes for the synthesis and use of such macrocyclic compounds for treating or preventing HCV infection.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Angela Mackay0
Frank Narjes0
Ian Stansfield0
Immacolata Conte0
Joerg Habermann0
Maria del Rosario Rico Ferreira0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07989438 Therapeutic compounds US Patent 7989438 Therapeutic compounds
Infobox
Patent Number
07989438
Patent Number
7989438
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07989438 Therapeutic compounds
Infobox
Is a
Patent jurisdiction
Patent number
07989438
Date of patent
August 2, 2011
Patent application number
12218425
Date Filed
July 15, 2008
Patent primary examiner
Find more entities like US Patent 7989438 Therapeutic compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
